Bangalore, India-- (SBWIRE) -- 08/09/2016 -- Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges) present around the brain and spinal cord. It can be classified into infectious and non-infectious meningitis. Based on the types of organism, infectious meningitis is sub-divided into bacterial meningitis, viral meningitis, fungal meningitis, and parasitic meningitis. Bacterial meningitis occurs due to bacterial species such as hemophilus influenzae, listeria monocytogenes, neisseria meningitidis, and streptococcus pneumoniae.

Report forecast the global meningococcal vaccines market to grow at a CAGR of 13.07% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global meningococcal vaccines market for 2016-2020. To calculate the market size, the report considers the the report considers the revenue generated from the sales of vaccines used to prevent meningococcal infections.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Meningococcal Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GSK
- Pfizer
- Sanofi

Other prominent vendors
- Beijing Minhai Biotechnology
- Bio Med
- Hualan Biological Engineering
- Imunoloski Zavod
- JN International Medical
- Nuron Biotech
- Serum Institute of India
- Vacunas Finlay SA
- Merck
- GlycoVaxyn
- Baxter

Market driver
- Designated as a traveller's vaccine
- For a full, detailed list, view our report

Market challenge
- High cost associated with vaccine development
- For a full, detailed list, view our report

Market trend
- Increase in strategic alliances and M&A
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 68 pages "Global Meningococcal Vaccines Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Overview of vaccines, Market landscape, Market segmentation by composition, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-meningococcal-vaccines-market-2016-2020

Related Reports:

Global Nuclear Medicine Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-nuclear-medicine-market-2016-2020

Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-cardiac-resynchronization-therapy-pacemaker-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.